What is the current Price Target for the Molecular Partners AG - ADR stock?

The average Molecular Partners AG - ADR target price is $13.29. This is 222.56% higher than the current stock price. The highest price target is 374.36%, the lowest is 82.51%. 5 Analysts have issued a price target Molecular Partners AG - ADR 2026 .

How high will the Molecular Partners AG - ADR stock rise?

No reliable answer can be given as to how high the Molecular Partners AG - ADR stock will rise. The performance of stocks, including the Molecular Partners AG - ADR stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Molecular Partners AG - ADR stock today?

The performance of Molecular Partners AG - ADR stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Molecular Partners AG - ADR stock fall?

The decline in Molecular Partners AG - ADR stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Molecular Partners AG - ADR Forecast, price target & analysts

$4.12

1.67% yesterday

Nasdaq, Nov 20, 10:00 pm CET

ISIN

US60853G1067

Symbol

MOLN

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Molecular Partners AG - ADR Target price 2025 - Analyst rating & recommendation

Molecular Partners AG - ADR Classifications & Recommendation:

Buy

78%

Hold

22%

Molecular Partners AG - ADR Price Target

Target Price	$13.29
Price	$4.12
Potential	222.56% register free of charge
Number of Estimates	5

	5 Analysts have issued a price target Molecular Partners AG - ADR 2026 . The average Molecular Partners AG - ADR target price is $13.29. This is 222.56% register free of charge higher than the current stock price. The highest price target is $19.54 374.36% register free of charge , the lowest is $7.52 82.51% register free of charge .
	A rating was issued by 9 analysts: 7 Analysts recommend Molecular Partners AG - ADR to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Molecular Partners AG - ADR stock has an average upside potential 2026 of 222.56% register free of charge . Most analysts recommend the Molecular Partners AG - ADR stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-1.97	-1.89
	16.17%	4.06%
P/E		negative
EV/Sales		33.81

4 Analysts have issued a Molecular Partners AG - ADR forecast for earnings per share. The average Molecular Partners AG - ADR EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-1.97	16.17%
2025	$-1.89 4.06% Unlock
2026	$-1.58 16.40% Unlock
2027	$-0.77 51.27% Unlock
2028	$-3.88 403.90% Unlock
2029	$-2.55 34.28% Unlock
2030	$-1.78 30.20% Unlock
2031	$-0.64 64.04% Unlock
2032	$1.91 398.44% Unlock

Current	-1.99	0.30%
2025	-2.18 9.53% Unlock
2026	-2.61 19.72% Unlock
2027	-5.38 106.13% Unlock
2028	-1.06 80.30% Unlock
2029	-1.62 52.83% Unlock
2030	-2.31 42.59% Unlock
2031	-6.47 180.09% Unlock
2032	2.16 133.38% Unlock

Molecular Partners AG - ADR...

Current Molecular Partners AG - ADR Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
TD COWEN	Locked ➜ Locked	Locked	Aug 26 2025
TD COWEN	Locked ➜ Locked	Locked	Jun 13 2025
TD COWEN	Locked ➜ Locked	Locked	Jun 12 2025
TD COWEN	Locked ➜ Locked	Locked	Mar 13 2025
TD COWEN	Locked ➜ Locked	Locked	Oct 31 2024

Analyst Rating	Date
Locked TD COWEN: Locked ➜ Locked	Aug 26 2025
Locked TD COWEN: Locked ➜ Locked	Jun 13 2025
Locked TD COWEN: Locked ➜ Locked	Jun 12 2025
Locked TD COWEN: Locked ➜ Locked	Mar 13 2025
Locked TD COWEN: Locked ➜ Locked	Oct 31 2024

Discover more stocks with a high price target

Netflix 1,241.72%

Coinbase Global, Inc. 73.03%

Adidas 57.44%

TUI 53.15%

Meta Platforms (Facebook) 51.49%

Novo Nordisk 48.54%

BioNTech SE - ADR 43.58%

BYD 43.53%

Deutsche Telekom 43.13%

Adyen 42.77%

PayPal 38.68%

Rheinmetall 37.08%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now